Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 199

1.

Cumulative Risk Distribution for Interval Invasive Second Breast Cancers After Negative Surveillance Mammography.

Lee JM, Abraham L, Lam DL, Buist DSM, Kerlikowske K, Miglioretti DL, Houssami N, Lehman CD, Henderson LM, Hubbard RA.

J Clin Oncol. 2018 Jul 10;36(20):2070-2077. doi: 10.1200/JCO.2017.76.8267. Epub 2018 May 2.

PMID:
29718790
2.

National Institutes of Health Pathways to Prevention Workshop: Methods for Evaluating Natural Experiments in Obesity.

Emmons KM, Doubeni CA, Fernandez ME, Miglioretti DL, Samet JM.

Ann Intern Med. 2018 Jun 5;168(11):809-814. doi: 10.7326/M18-0501. Epub 2018 May 1.

PMID:
29710235
3.

Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study.

Kerlikowske K, Scott CG, Mahmoudzadeh AP, Ma L, Winham S, Jensen MR, Wu FF, Malkov S, Pankratz VS, Cummings SR, Shepherd JA, Brandt KR, Miglioretti DL, Vachon CM.

Ann Intern Med. 2018 Jun 5;168(11):757-765. doi: 10.7326/M17-3008. Epub 2018 May 1.

PMID:
29710124
4.

Common Model Inputs Used in CISNET Collaborative Breast Cancer Modeling.

Mandelblatt JS, Near AM, Miglioretti DL, Munoz D, Sprague BL, Trentham-Dietz A, Gangnon R, Kurian AW, Weedon-Fekjaer H, Cronin KA, Plevritis SK.

Med Decis Making. 2018 Apr;38(1_suppl):9S-23S. doi: 10.1177/0272989X17700624.

PMID:
29554466
5.

Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.

Braithwaite D, Miglioretti DL, Zhu W, Demb J, Trentham-Dietz A, Sprague B, Tice JA, Onega T, Henderson LM, Buist DSM, Ziv E, Walter LC, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2018 Apr 1;178(4):494-501. doi: 10.1001/jamainternmed.2017.8642.

PMID:
29435563
6.

Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system.

Winer RL, Tiro JA, Miglioretti DL, Thayer C, Beatty T, Lin J, Gao H, Kimbel K, Buist DSM.

Contemp Clin Trials. 2018 Jan;64:77-87. doi: 10.1016/j.cct.2017.11.004. Epub 2017 Nov 4.

PMID:
29113956
7.

Emerging Trends in Family History of Breast Cancer and Associated Risk.

Shiyanbola OO, Arao RF, Miglioretti DL, Sprague BL, Hampton JM, Stout NK, Kerlikowske K, Braithwaite D, Buist DSM, Egan KM, Newcomb PA, Trentham-Dietz A.

Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1753-1760. doi: 10.1158/1055-9965.EPI-17-0531. Epub 2017 Oct 6.

PMID:
28986348
8.

Combining quantitative and qualitative breast density measures to assess breast cancer risk.

Kerlikowske K, Ma L, Scott CG, Mahmoudzadeh AP, Jensen MR, Sprague BL, Henderson LM, Pankratz VS, Cummings SR, Miglioretti DL, Vachon CM, Shepherd JA.

Breast Cancer Res. 2017 Aug 22;19(1):97. doi: 10.1186/s13058-017-0887-5.

9.

Mammography Performance Benchmarks in an Era of Value-based Care.

Lee JM, Miglioretti DL, Burnside ES, Morris EA, Smith RA, Lehman CD.

Radiology. 2017 Aug;284(2):605-607. doi: 10.1148/radiol.2017170638. No abstract available.

10.

Performance Benchmarks for Screening Breast MR Imaging in Community Practice.

Lee JM, Ichikawa L, Valencia E, Miglioretti DL, Wernli K, Buist DSM, Kerlikowske K, Henderson LM, Sprague BL, Onega T, Rauscher GH, Lehman CD.

Radiology. 2017 Oct;285(1):44-52. doi: 10.1148/radiol.2017162033. Epub 2017 Jun 5.

PMID:
28582633
11.

Correlation Between Screening Mammography Interpretive Performance on a Test Set and Performance in Clinical Practice.

Miglioretti DL, Ichikawa L, Smith RA, Buist DSM, Carney PA, Geller B, Monsees B, Onega T, Rosenberg R, Sickles EA, Yankaskas BC, Kerlikowske K.

Acad Radiol. 2017 Oct;24(10):1256-1264. doi: 10.1016/j.acra.2017.03.016. Epub 2017 May 24.

PMID:
28551400
12.

National Performance Benchmarks for Modern Diagnostic Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Sprague BL, Arao RF, Miglioretti DL, Henderson LM, Buist DS, Onega T, Rauscher GH, Lee JM, Tosteson AN, Kerlikowske K, Lehman CD; Breast Cancer Surveillance Consortium.

Radiology. 2017 Apr;283(1):59-69. doi: 10.1148/radiol.2017161519. Epub 2017 Feb 28.

13.

Population-Attributable Risk Proportion of Clinical Risk Factors for Breast Cancer.

Engmann NJ, Golmakani MK, Miglioretti DL, Sprague BL, Kerlikowske K; Breast Cancer Surveillance Consortium.

JAMA Oncol. 2017 Sep 1;3(9):1228-1236. doi: 10.1001/jamaoncol.2016.6326.

PMID:
28152151
14.

Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors.

Engmann NJ, Scott CG, Jensen MR, Ma L, Brandt KR, Mahmoudzadeh AP, Malkov S, Whaley DH, Hruska CB, Wu FF, Winham SJ, Miglioretti DL, Norman AD, Heine JJ, Shepherd J, Pankratz VS, Vachon CM, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):930-937. doi: 10.1158/1055-9965.EPI-16-0882. Epub 2017 Feb 1.

15.

Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.

Ahern TP, Sprague BL, Bissell MCS, Miglioretti DL, Buist DSM, Braithwaite D, Kerlikowske K.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):938-944. doi: 10.1158/1055-9965.EPI-16-0801. Epub 2017 Jan 17.

16.

Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.

Kerlikowske K, Gard CC, Tice JA, Ziv E, Cummings SR, Miglioretti DL; Breast Cancer Surveillance Consortium.

J Natl Cancer Inst. 2016 Dec 31;109(5). doi: 10.1093/jnci/djw276. Print 2017 May.

17.

National Performance Benchmarks for Modern Screening Digital Mammography: Update from the Breast Cancer Surveillance Consortium.

Lehman CD, Arao RF, Sprague BL, Lee JM, Buist DS, Kerlikowske K, Henderson LM, Onega T, Tosteson AN, Rauscher GH, Miglioretti DL.

Radiology. 2017 Apr;283(1):49-58. doi: 10.1148/radiol.2016161174. Epub 2016 Dec 5.

18.

Radiologist Agreement for Mammographic Recall by Case Difficulty and Finding Type.

Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B.

J Am Coll Radiol. 2016 Nov;13(11S):e72-e79. doi: 10.1016/j.jacr.2016.09.035.

PMID:
27814827
19.

Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next Steps.

Marcus PM, Pashayan N, Church TR, Doria-Rose VP, Gould MK, Hubbard RA, Marrone M, Miglioretti DL, Pharoah PD, Pinsky PF, Rendle KA, Robbins HA, Roberts MC, Rolland B, Schiffman M, Tiro JA, Zauber AG, Winn DM, Khoury MJ.

Cancer Epidemiol Biomarkers Prev. 2016 Nov;25(11):1449-1455. Epub 2016 Aug 9.

20.

Radiation-Induced Breast Cancer.

Miglioretti DL, Lee CI.

Ann Intern Med. 2016 Sep 20;165(6):452. doi: 10.7326/L16-0364. No abstract available.

PMID:
27653715
21.

Subsequent Breast Cancer Risk Following Diagnosis of Atypical Ductal Hyperplasia on Needle Biopsy.

Menes TS, Kerlikowske K, Lange J, Jaffer S, Rosenberg R, Miglioretti DL.

JAMA Oncol. 2017 Jan 1;3(1):36-41. doi: 10.1001/jamaoncol.2016.3022.

22.

Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer Patients.

Sherman ME, Ichikawa L, Pfeiffer RM, Miglioretti DL, Kerlikowske K, Tice J, Vacek PM, Gierach GL.

PLoS One. 2016 Aug 25;11(8):e0160966. doi: 10.1371/journal.pone.0160966. eCollection 2016.

23.

Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.

Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, Mandelblatt JS, Tosteson AN; Breast Cancer Surveillance Consortium and the Cancer Intervention and Surveillance Modeling Network.

Ann Intern Med. 2016 Nov 15;165(10):700-712. doi: 10.7326/M16-0476. Epub 2016 Aug 23.

24.

Radiologists' interpretive skills in screening vs. diagnostic mammography: are they related?

Elmore JG, Cook AJ, Bogart A, Carney PA, Geller BM, Taplin SH, Buist DS, Onega T, Lee CI, Miglioretti DL.

Clin Imaging. 2016 Nov - Dec;40(6):1096-1103. doi: 10.1016/j.clinimag.2016.06.014. Epub 2016 Jul 1.

25.

Predictors of CT Radiation Dose and Their Effect on Patient Care: A Comprehensive Analysis Using Automated Data.

Smith-Bindman R, Wang Y, Yellen-Nelson TR, Moghadassi M, Wilson N, Gould R, Seibert A, Boone JM, Krishnam M, Lamba R, Hall DJ, Miglioretti DL.

Radiology. 2017 Jan;282(1):182-193. doi: 10.1148/radiol.2016151391. Epub 2016 Jul 20.

26.

Digital Breast Tomosynthesis: A Brave New World of Mammography Screening.

Houssami N, Miglioretti DL.

JAMA Oncol. 2016 Jun 1;2(6):725-7. doi: 10.1001/jamaoncol.2015.5569. No abstract available. Erratum in: JAMA Oncol. 2016 Jun 1;2(6):833.

PMID:
26892954
27.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Service Task Force [Internet].

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2016 Jan.

28.

Who Gets to Decide?

Smith-Bindman R, Kwan ML, Miglioretti DL.

Radiology. 2016 Feb;278(2):635-6. doi: 10.1148/radiol.2015151682. No abstract available.

PMID:
26789608
29.

Cost Analysis of the STONE Randomized Trial: Can Health Care Costs be Reduced One Test at a Time?

Melnikow J, Xing G, Cox G, Leigh P, Mills L, Miglioretti DL, Moghadassi M, Smith-Bindman R.

Med Care. 2016 Apr;54(4):337-42. doi: 10.1097/MLR.0000000000000487.

PMID:
26759975
30.

Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force.

Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K.

Ann Intern Med. 2016 Feb 16;164(4):268-78. doi: 10.7326/M15-1789. Epub 2016 Jan 12. Review.

31.

Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.

Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, Hoeffken A, Chang Y, Heijnsdijk EA, Chisholm G, Huang X, Huang H, Ergun MA, Gangnon R, Sprague BL, Plevritis S, Feuer E, de Koning HJ, Cronin KA.

Ann Intern Med. 2016 Feb 16;164(4):215-25. doi: 10.7326/M15-1536. Epub 2016 Jan 12.

32.

Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.

Miglioretti DL, Lange J, van den Broek JJ, Lee CI, van Ravesteyn NT, Ritley D, Kerlikowske K, Fenton JJ, Melnikow J, de Koning HJ, Hubbard RA.

Ann Intern Med. 2016 Feb 16;164(4):205-14. doi: 10.7326/M15-1241. Epub 2016 Jan 12.

33.

Statistical Methods for Estimating the Cumulative Risk of Screening Mammography Outcomes.

Hubbard RA, Ripping TM, Chubak J, Broeders MJ, Miglioretti DL.

Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):513-20. doi: 10.1158/1055-9965.EPI-15-0824. Epub 2015 Dec 31.

34.

Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.

Miglioretti DL, Zhu W, Kerlikowske K, Sprague BL, Onega T, Buist DS, Henderson LM, Smith RA; Breast Cancer Surveillance Consortium.

JAMA Oncol. 2015 Nov;1(8):1069-77. doi: 10.1001/jamaoncol.2015.3084.

35.

Diagnostic Accuracy of Digital Screening Mammography With and Without Computer-Aided Detection.

Lehman CD, Wellman RD, Buist DS, Kerlikowske K, Tosteson AN, Miglioretti DL; Breast Cancer Surveillance Consortium.

JAMA Intern Med. 2015 Nov;175(11):1828-37. doi: 10.1001/jamainternmed.2015.5231.

36.

Breast Cancer Characteristics Associated With Digital Versus Film-Screen Mammography for Screen-Detected and Interval Cancers.

Henderson LM, Miglioretti DL, Kerlikowske K, Wernli KJ, Sprague BL, Lehman CD.

AJR Am J Roentgenol. 2015 Sep;205(3):676-84. doi: 10.2214/AJR.14.13904.

37.

Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer.

Tice JA, Miglioretti DL, Li CS, Vachon CM, Gard CC, Kerlikowske K.

J Clin Oncol. 2015 Oct 1;33(28):3137-43. doi: 10.1200/JCO.2015.60.8869. Epub 2015 Aug 17.

38.

Facility Mammography Volume in Relation to Breast Cancer Screening Outcomes.

Onega T, Goldman LE, Walker RL, Miglioretti DL, Buist DS, Taplin S, Geller BM, Hill DA, Smith-Bindman R.

J Med Screen. 2016 Mar;23(1):31-7. doi: 10.1177/0969141315595254. Epub 2015 Aug 11.

PMID:
26265482
39.

Patient and Radiologist Characteristics Associated With Accuracy of Two Types of Diagnostic Mammograms.

Jackson SL, Abraham L, Miglioretti DL, Buist DS, Kerlikowske K, Onega T, Carney PA, Sickles EA, Elmore JG.

AJR Am J Roentgenol. 2015 Aug;205(2):456-63. doi: 10.2214/AJR.14.13672.

40.

Misclassification of Breast Imaging Reporting and Data System (BI-RADS) Mammographic Density and Implications for Breast Density Reporting Legislation.

Gard CC, Aiello Bowles EJ, Miglioretti DL, Taplin SH, Rutter CM.

Breast J. 2015 Sep-Oct;21(5):481-9. doi: 10.1111/tbj.12443. Epub 2015 Jul 1.

41.

Computed Tomography Radiation Dose in Patients With Suspected Urolithiasis.

Smith-Bindman R, Moghadassi M, Griffey RT, Camargo CA Jr, Bailitz J, Beland M, Miglioretti DL.

JAMA Intern Med. 2015 Aug;175(8):1413-6. doi: 10.1001/jamainternmed.2015.2697. No abstract available.

PMID:
26121191
42.

Radiation Doses in Consecutive CT Examinations from Five University of California Medical Centers.

Smith-Bindman R, Moghadassi M, Wilson N, Nelson TR, Boone JM, Cagnon CH, Gould R, Hall DJ, Krishnam M, Lamba R, McNitt-Gray M, Seibert A, Miglioretti DL.

Radiology. 2015 Oct;277(1):134-41. doi: 10.1148/radiol.2015142728. Epub 2015 May 19.

43.

Identifying women with dense breasts at high risk for interval cancer: a cohort study.

Kerlikowske K, Zhu W, Tosteson AN, Sprague BL, Tice JA, Lehman CD, Miglioretti DL; Breast Cancer Surveillance Consortium.

Ann Intern Med. 2015 May 19;162(10):673-81. doi: 10.7326/M14-1465.

44.

Radiographers supporting radiologists in the interpretation of screening mammography: a viable strategy to meet the shortage in the number of radiologists.

Torres-Mejía G, Smith RA, Carranza-Flores Mde L, Bogart A, Martínez-Matsushita L, Miglioretti DL, Kerlikowske K, Ortega-Olvera C, Montemayor-Varela E, Angeles-Llerenas A, Bautista-Arredondo S, Sánchez-González G, Martínez-Montañez OG, Uscanga-Sánchez SR, Lazcano-Ponce E, Hernández-Ávila M.

BMC Cancer. 2015 May 16;15:410. doi: 10.1186/s12885-015-1399-2.

45.

One versus Two Breast Density Measures to Predict 5- and 10-Year Breast Cancer Risk.

Kerlikowske K, Gard CC, Sprague BL, Tice JA, Miglioretti DL; Breast Cancer Surveillance Consortium.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):889-97. doi: 10.1158/1055-9965.EPI-15-0035. Epub 2015 Mar 30.

46.

Criteria for identifying radiologists with acceptable screening mammography interpretive performance on basis of multiple performance measures.

Miglioretti DL, Ichikawa L, Smith RA, Bassett LW, Feig SA, Monsees B, Parikh JR, Rosenberg RD, Sickles EA, Carney PA.

AJR Am J Roentgenol. 2015 Apr;204(4):W486-91. doi: 10.2214/AJR.13.12313.

47.

Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts.

Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN.

Ann Intern Med. 2015 Feb 3;162(3):157-66. doi: 10.7326/M14-0692.

48.

Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.

Johnson JM, Johnson AK, O'Meara ES, Miglioretti DL, Geller BM, Hotaling EN, Herschorn SD.

Radiology. 2015 Apr;275(1):54-60. doi: 10.1148/radiol.14140036. Epub 2014 Nov 25.

49.

Comparative effectiveness of combined digital mammography and tomosynthesis screening for women with dense breasts.

Lee CI, Cevik M, Alagoz O, Sprague BL, Tosteson AN, Miglioretti DL, Kerlikowske K, Stout NK, Jarvik JG, Ramsey SD, Lehman CD.

Radiology. 2015 Mar;274(3):772-80. doi: 10.1148/radiol.14141237. Epub 2014 Oct 28.

50.

Ultrasonography versus computed tomography for suspected nephrolithiasis.

Smith-Bindman R, Aubin C, Bailitz J, Bengiamin RN, Camargo CA Jr, Corbo J, Dean AJ, Goldstein RB, Griffey RT, Jay GD, Kang TL, Kriesel DR, Ma OJ, Mallin M, Manson W, Melnikow J, Miglioretti DL, Miller SK, Mills LD, Miner JR, Moghadassi M, Noble VE, Press GM, Stoller ML, Valencia VE, Wang J, Wang RC, Cummings SR.

N Engl J Med. 2014 Sep 18;371(12):1100-10. doi: 10.1056/NEJMoa1404446.

Supplemental Content

Loading ...
Support Center